XML 43 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Stock Options and Restricted Stock (Tables)
 6 Months Ended
Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Assumption Categories Used to Determine Value of Option Grants The following assumption categories are used to determine the value of any option grants.

 

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

Risk free interest rate

 

 

1.46

%

 

 

2.39

%

Expected dividend yield

 

 

—

 

 

 

0.79

 

Expected life of option in years(1)

 

 

6.25

 

 

 

6.25

 

Expected volatility(2)

 

 

50.18

 

 

 

48.45

 

 

(1)

Expected life is calculated using the simplified method.

(2)

We determine our expected volatility based on our historical volatility.

Summary of Activity for Stock Option Programs

The following table presents the activity for the stock option programs for the 2020 first and second quarters and the 2019 full year.

 

 

 

Number of

Options

 

 

 

Exercise

Price Per

Share

 

 

Weighted

Average

Exercise Price

 

Outstanding at December 31, 2018

 

 

144,666

 

 

$

2.14-13.84

 

 

$

7.23

 

Granted

 

 

449,450

 

 

 

5.21-7.25

 

 

 

6.61

 

Cancelled

 

 

(44,076

)

 

 

6.55-13.84

 

 

 

9.00

 

Exercised(1)

 

 

—

 

 

 

 

—

 

 

 

—

 

Outstanding at December 31, 2019

 

 

550,040

 

 

 

2.14-13.53

 

 

 

6.58

 

Granted

 

 

335,773

 

 

 

 

6.68

 

 

 

6.68

 

Cancelled

 

 

(14,585

)

 

 

6.55-7.25

 

 

 

6.67

 

Exercised(1)

 

 

—

 

 

 

 

—

 

 

 

—

 

Outstanding at March 31, 2020

 

 

871,228

 

 

 

2.14-13.53

 

 

 

6.62

 

Granted

 

 

—

 

 

 

 

—

 

 

 

—

 

Cancelled

 

 

(1,623

)

 

 

6.55-7.25

 

 

 

6.90

 

Exercised(1)

 

 

—

 

 

 

 

—

 

 

 

—

 

Outstanding at June 30, 2020

 

 

869,605

 

 

$

2.14-13.53

 

 

$

6.62

 

Options exercisable at June 30, 2020(2)

 

 

179,079

 

 

 

2.14-13.53

 

 

 

6.63

 

 

(1)

The aggregate intrinsic value, which represents the difference between the price of the Company’s common stock at the exercise date and the related exercise price of the underlying options, was $0 for the three and six months ended June 30, 2020 and 2019.

(2)

The aggregate intrinsic value, which represents the difference between the price of the Company’s common stock at June 30, 2020 and the related exercise price of the underlying options, was $9,000 for outstanding options and $8,000 for exercisable options as of June 30, 2020. The remaining contractual life was 8.85 years for outstanding options and 7.49 years for exercisable options at June 30, 2020.

Summary of Activity for Restricted Stock Programs

The following table presents the activity for the restricted stock programs for the 2020 first and second quarters and the 2019 full year.

 

 

 

Number of

Shares

 

 

 

Grant

Price Per

Share

 

 

Weighted

Average

Exercise Price

 

Outstanding at December 31, 2018

 

 

190,915

 

 

$

2.14-5.27

 

 

$

4.06

 

Granted

 

 

216,148

 

 

 

4.80-7.25

 

 

 

6.59

 

Cancelled

 

 

(3,946

)

 

 

3.93-6.55

 

 

 

4.97

 

Vested(1)

 

 

(118,238

)

 

 

2.06-4.80

 

 

 

3.89

 

Outstanding at December 31, 2019

 

 

284,879

 

 

 

3.95-7.25

 

 

 

6.01

 

Granted

 

 

165,674

 

 

 

 

6.68

 

 

 

6.68

 

Cancelled

 

 

(5,577

)

 

 

3.95-7.25

 

 

 

6.67

 

Vested(1)

 

 

(81,337

)

 

 

3.95-6.55

 

 

 

5.41

 

Outstanding at March 31, 2020

 

 

363,639

 

 

 

4.39-7.25

 

 

 

6.44

 

Granted

 

 

—

 

 

 

 

—

 

 

 

—

 

Cancelled

 

 

(696

)

 

 

6.55-7.25

 

 

 

6.97

 

Vested(1)

 

 

—

 

 

 

 

—

 

 

 

—

 

Outstanding at June 30, 2020(2)

 

 

362,943

 

 

$

4.39-7.25

 

 

$

6.44

 

 

(1)

The aggregate fair value of the restricted stock vested was $0 and $553,000 for the three and six months ended June 30, 2020, and was $113,000 and $736,000 for the three and six months ended June 30, 2019.

(2)

The aggregate fair value of the restricted stock was $962,000 as of June 30, 2020. The remaining vesting period was 2.45 years at June 30, 2020.

Summary of Activity for Unvested Options Outstanding

The following table presents the activity for the unvested options outstanding under the plans for the 2020 first and second quarters.

 

 

 

Number of

Options

 

 

 

Exercise

Price

Per Share

 

 

Weighted

Average

Exercise Price

 

Outstanding at December 31, 2019

 

 

487,262

 

 

$

2.14-7.25

 

 

$

6.45

 

Granted

 

 

335,773

 

 

 

 

6.68

 

 

 

6.68

 

Cancelled

 

 

(14,148

)

 

 

6.55-7.25

 

 

 

6.68

 

Vested

 

 

(104,939

)

 

 

 

6.55

 

 

 

6.55

 

Outstanding at March 31, 2020

 

 

703,948

 

 

 

2.14-7.25

 

 

 

6.21

 

Granted

 

 

—

 

 

 

 

—

 

 

 

—

 

Cancelled

 

 

(1,422

)

 

 

6.55-7.25

 

 

 

6.95

 

Vested

 

 

(12,000

)

 

 

2.22-5.58

 

 

 

4.46

 

Outstanding at June 30, 2020

 

 

690,526

 

 

$

2.14-7.25

 

 

$

6.61